Pricing Log in Create free account

Rein Therapeutics Inc. (RNTX) vs Verrica Pharmaceuticals Inc. (VRCA)

Rein Therapeutics Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. Rein Therapeutics Inc. and Verrica Pharmaceuticals Inc. are of similar size ($53.1M and $52.8M). Rein Therapeutics Inc. has the higher net margin (0.00% vs −102.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Rein Therapeutics Inc. leads on 8 and Verrica Pharmaceuticals Inc. on 5.

Valuation

Metric RNTX VRCA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.26 9.40
P/B 4.01 15.93 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 2.33 9.02
Earnings yield (281.97%) (51.86%) (32.88%)
Free cash flow yield (45.77%) (19.81%) (23.13%)

Profitability

Metric RNTX VRCA Biotechnology median
Gross margin 0.00% 85.89% 68.51%
Operating margin 0.00% (93.59%) 0.00%
Net margin 0.00% (102.84%) 0.00%
Free cash flow margin 0.00% (44.02%) 0.00%
Return on equity (753.55%) 473.29% (51.96%)
Return on assets (80.62%) (83.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RNTX VRCA Biotechnology median
Revenue growth (TTM) — 106.21% 6.76%
EPS growth (last fiscal year) 44.16% 88.65% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RNTX VRCA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 4.27 1.45 4.97
Net debt to EBITDA 0.15 2.59 1.01

Dividend

Metric RNTX VRCA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric RNTX VRCA Biotechnology median
Market cap 52.79m 53.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack